SavedAdd your journal

Journals / Göztepe Tıp Dergisi / 2003 / Cilt: 18 - Sayı: 4

The relationship between immunglobulin levels and microvasculer complication in diabetic patients

Diabetes mellituslu hastalarda immunglobulin düzeyinin mikrovasküler komplikasyonlar ile ilişkisi

Gülşen TÜKENMEZ
Damla Burçak EYİNÇ
Turgay ÖZAY
Ahmet AĞRIŞ
Ayça KAYA
Arslan DAĞAR
Pages
220–224
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

They were classified according to diabet period, insulin or oral antidiabetic treatment duration, HbA1c, immunoglobulin levels, microalbuminurea, neuropathy and rethinopathy presence.IgA level in patients with diabet period more than 10 years were higher than the patients in control group and the patients with diabet period less than 10 years (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To investigate the relationship between immunoglobulin levels and microvasculer complications in diabetic patients, 82 type 2 diabetic patients were involved in our study and 38 non-diabetic patients were involved as a control group.
📊
Key Findings & Data:To investigate the relationship between immunoglobulin levels and microvasculer complications in diabetic patients, 82 type 2 diabetic patients were involved in our study and 38 non-diabetic patients were involved as a control group.
💡
Conclusion & Impact:They were classified according to diabet period, insulin or oral antidiabetic treatment duration, HbA1c, immunoglobulin levels, microalbuminurea, neuropathy and rethinopathy presence.IgA level in patients with diabet period more than 10 years were higher than the patients in control group and the patients with diabet period less than 10 years (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

To investigate the relationship between immunoglobulin levels and microvasculer complications in diabetic patients, 82 type 2 diabetic patients were involved in our study and 38 non-diabetic patients were involved as a control group. They were classified according to diabet period, insulin or oral antidiabetic treatment duration, HbA1c, immunoglobulin levels, microalbuminurea, neuropathy and rethinopathy presence.IgA level in patients with diabet period more than 10 years were higher than the patients in control group and the patients with diabet period less than 10 years (p

Özet

Bu çalışmada diabetes mellituslu olgularda serum immünglobulin düzeyleri ile mikrovasküler komplikasyonlar, glukoz regülasyonu diabet süresi ve tedavi rejimleri arasındaki ilişki araştırıldı. 84 tip II diabet (yaş ortalaması:53.4±11.7) ve 38 nondiabetik (yaş ortalaması:49.2±14.8) çalışmaya alındı. Olguların klinik ve biyokimyasal değerleri kaydedildi. Serum immünglobulin düzeyleri ölçüldü.Diabet süresi 10 yıldan fazla olanlarda, IgA düzeyi, kontrol grubu ve diabet süresi 10 yıldan az olanlara göre yüksek bulundu (p% 10), IgA düzeyleri diğer olgulara göre anlamlı derecede yüksekti (p

🔖

Cite This Article

TÜKENMEZ, G., EYİNÇ, D. B., ÖZAY, T., AĞRIŞ, A., KAYA, A., DAĞAR, A. (2022). The relationship between immunglobulin levels and microvasculer complication in diabetic patients. Göztepe Tıp Dergisi, Cilt: 18 - Sayı: 4, 220–224. https://ajindex.com/articles/526474

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Candeğer Yılmaz: Endokrinolojide tanı basamakları, Diabetes Mellitus. Candeğer Yılmaz, 2003, İzmir, yayınevi Güven Kitapevi, ciltno:40-41
  2. Zel'tser ME, Narodetskaia LN, MakarovaTB: immünglobulin levels in the blood of persons with diabetes mellitus risk factors. Probl Endocrinolgy 33(4):18-20, 1987
  3. Gill CW, Bush WS, Burleigh WM, Cooke-Gomes D: Elevation of IgA levels in the non-insulin-dependent diabetik patients. Diabetes Care 4(6):636-639, 1981
  4. Unger RH, Foster DW: Diabetes Mellitus. In: Wilson JD, FosterDW (eds). Willams Textbook of Endocrinology. Seventh edition. Philadelphia. WB Saunders Company: 1255-1263, 1992
  5. Dökmetaş SH, Topçu S, Hocaoğlu L, Türkay C, İçağasıoığlu S: Diabetik hastalarda immünglobulin düzeyleri. CÜ Tıp F. Dergisi 2:133-138, 1997
  6. Danze PM, Tarjoman A: Evidense for an increased glycation of immunglobulins in diabetic patients. Clinica Chimica Acta 166:143-153, 1987
  7. Dolhofer R, Siess EA, Wieland OH: Nonenzimatik glycation of immunglobulins leads to an impairment of immunreaktive. Biol Chem 361-366, 1985
  8. Gorus FK, Wandevalve CL, Winnock F, Lebleu F: Increased prevalance of abnormal immunglobulins at clinical onset of NIDDM: Pancreas 16(l):50-59, 1998
  9. Cheta D, Stokag, Cheta N: Decrease of serum immünglobulin M levels in some diabetic patients: Med Interne 27(3):219-223, 1989
  10. Armbruster D: Fructosamin structure analysis, and clinical use-fullness. Clin Chem 33:2153-2163, 1987
  11. Ardaw İMSM, Nasrat HAN: Serum immünglobulin consantrations in diabetic patients. Diabetic Med 11:384-387, 1994
  12. Rodrigez-Segade S, Camina MF, Paz JM, Del Rio R: High serum IgA concentrations in patients with diabetes mellitus: agewise distrubition and relation to chronic complications. Clinical Chemistry 42(7):1064-1067, 1996
  13. Casiglia D, Giardina E, Scatantino G: Increased plasma levels of IgA-IgG immuncomplexes and anti-F(ab) 2antibodies inpatients with type 2 (non insulin dependent) diabetes mellitus and microan-jiopathy. Diabetes Res 15(4): 195-200, 1990
  14. Kaneshige H: Nonenzymatic glycosylation of serum IgG and its effect on antibody activity in patients with diabetes mellitus. Diabetes 36:822-828, 1987
  15. Kesaniemi YA,Witztum JL, Steinbrecter vp: Receptor-mediated clearence of of LDL in man new watimwtes using glucosylated LDL. Clin Invest 1983, 828
  16. Zoppi F, Mosca A: Glcated proteins in serum: Effect of their relative proportiom on their alkaline reducing activity in the froktozamin test Clin Chem 3